跳至主要内容
临床试验/CTRI/2023/07/055908
CTRI/2023/07/055908尚未招募3 期

Comparison of Adjuvant Chemoradiotherapy versus Adjuvant Chemotherapy in carcinoma gall bladder- A phase III randomized controlled study - CRT-GB

All India Institute of Medical Sciences Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Eastern Cooperative Oncology Group (ECOG) Performance Score- 0-1
  • 2. Newly diagnosed, primary gall bladder adenocarcinoma, after radical cholecystectomy with at least one of the following criteria:
  • i. PT3 or PT4
  • ii. Lymph node-positive
  • iii. Margin positive
  • iv. PT2 with lymphovascular invasion (LVI) or perineural invasion (PNI) or poorly differentiated tumor.
  • 3. Hematological parameters, liver function test, Kidney function test, and cardiac function within normal limits.

排除标准

  • 1. Inoperable carcinoma gall bladder or with metastasis
  • 2. Previous history of any treatment (chemotherapy, radiotherapy or surgery) for cancer
  • 3. Previous radiotherapy to the abdominal or pelvic region
  • 4. Recurrent gall bladder carcinoma
  • 5. ECOG performance score 2-4
  • 6. Clinically significant cardiac disease and liver dysfunction
  • 7. Pregnant patients

研究者

发起方
All India Institute of Medical Sciences Bhubaneswar

相似试验